Symbol="FRLN"
AssetType="Common Stock"
Name="Freeline TherapeuticsÂ Holdings Plc"
Description="Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops vector-mediated adeno-associated virus (AAV) transforming gene therapies for patients suffering from inherited systemic debilitating diseases. The company is headquartered in Stevenage, the United Kingdom."
CIK="1810031"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="STEVENAGE BIOSCIENCE CATALYST, GUNNELS WOOD ROAD, STEVENAGE, HERTFORDSHIRE, GB"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="18546900"
EBITDA="-84667000"
PERatio="None"
PEGRatio="None"
BookValue="12.89"
DividendPerShare="0"
DividendYield="0"
EPS="-11.02"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.388"
ReturnOnEquityTTM="-0.7"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-11.02"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="12.8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.559"
EVToRevenue="-"
EVToEBITDA="0.146"
Beta="0.707"
num_52WeekHigh="14.4"
num_52WeekLow="2.11"
num_50DayMovingAverage="3.531"
num_200DayMovingAverage="6.26"
SharesOutstanding="4343500"
DividendDate="None"
ExDividendDate="None"
symbol="FRLN"
open="4.25"
high="4.39"
low="4.21"
price="4.22"
volume="11429.00"
latest_trading_day="2023-08-21"
previous_close="4.40"
change="-0.18"
change_percent="-4.0909%"
aroon_positive_momentum_days="29"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="29"
Volume_recent_avg="325452"
Change_recent_avg="0.02"
Delta_recent_avg="0.37"
Variance_recent_avg="0.18"
Change_ratio_recent_avg="-1.25"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="29"
Aroon_momentum_negative="71"
image_negative_thumbnail_id_1="155"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0021.jpeg"
image_negative_thumbnail_id_2="1117"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0150.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="666"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0042.jpeg"
image_positive_thumbnail_id_2="949"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0111.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
